EMEA-002527-PIP01-18

Key facts

Active substance
Seladelpar
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0192/2019
PIP number
EMEA-002527-PIP01-18
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of primary biliary cholangitis
Route(s) of administration
Oral use
Contact for public enquiries
CymaBay Ireland Limited

Tel.: +1 5102938800
E-mail: cbueno@cymabay.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating